TheProfitWatch

MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.6 -0.15 (-9.38%) -0.01 (-0.68%) -0.03 (-2.03%) -0.05 (-3.33%) -0.05 (-3.13%) -0.01 (-0.65%) -0.07 (-4.61%) -0.07 (-4.61%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-16.1111
Diluted P/E:
-16.1111
RSI(14) 1m:
0.0
VWAP:
1.45
RVol:
0.1721

Events

Period Kind Movement Occurred At

Related News